title: [How does the oncology internist use pathology reports on tumor differentiation and heterogeneity?].
authors.forename: G A
authors.initials: GA
authors.lastname: Nagel
authors.forename: D
authors.initials: D
authors.lastname: Meyer
authors.forename: A
authors.initials: A
authors.lastname: Schauer
authors.forename: M
authors.initials: M
authors.lastname: Bergholz
authors.forename: G
authors.initials: G
authors.lastname: Krieger
authors.forename: M
authors.initials: M
authors.lastname: Kneba
mesh_terms: D002454:Cell Differentiation; D004351:Drug Resistance; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000473:pathology; D011379:Prognosis; D011987:Receptors, Steroid / Q000032:analysis
chemical_list: D011987:Receptors, Steroid
vernacular_title: Was fängt der internistische Onkologe mit den Aussagen des Pathologen über Tumordifferenzierung und -heterogenität an?